1.
Armstrong A, Wollenberg A, de Bruin-Weller M, Lio PA, Natalie CR, Zhao F, Reck Atwater A, Jimenez G, Chu C-Y, Vestergaard C. Conjunctivitis Does Not Increase With Longer Duration of Lebrikizumab Exposure in Patients With Moderate-to-Severe Atopic Dermatitis. J of Skin [Internet]. 2023Nov.13 [cited 2024Jul.3];7(6):s276. Available from: https://jofskin.org/index.php/skin/article/view/2386